首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Acute toxicity and in vivo biodistribution of monodispersed mesoporous bioactive glass spheres in intravenously exposed mice
【24h】

Acute toxicity and in vivo biodistribution of monodispersed mesoporous bioactive glass spheres in intravenously exposed mice

机译:静脉内暴露的小鼠中的单分散介孔生物活性玻璃球的急性毒性和体内生物分布

获取原文
获取原文并翻译 | 示例
       

摘要

The use of biomaterials from laboratories to clinics requires exhaustive and elaborate studies involving the biodistribution, clearance, and biocompatibility of biomaterials for in vivo biomedical applications. This study aimed to evaluate the acute toxicity and biodistribution of intravenously administrated sub-micrometer mesoporous bioactive glass spheres (SMBGs) in mice. The lethal dose 50 (LD50) of SMBGs was higher than 250 mg/kg. The acute toxicity was evaluated at 14 days after intravenous injection of SMBGs at 20, 100 and 180 mg/kg in ICR mice. The mortality, coefficients of major organs, hematology data and blood biochemical indexes revealed the low in vivo toxicity of SMBGs at all doses. However, the histological examination showed lymphocytic infiltration and granuloma formation in hepatocyte and megakaryocyte hyperplasia in the spleen at high dose. The silicon content analysis using ICP-OES and TEM results indicated that SMBGs mainly distributed in the resident macrophages of the liver and spleen, and could be cleared from the body more than 2 weeks. These findings can be important for the toxicity assessment of sub-micrometer particles and the development of bioactive glass based drug delivery system for biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
机译:从实验室到诊所使用生物材料,需要详尽而详尽的研究,涉及用于体内生物医学应用的生物材料的生物分布,清除和生物相容性。这项研究旨在评估小鼠静脉注射亚微米介孔生物活性玻璃球的急性毒性和生物分布。 SMBG的致死剂量50(LD50)高于250 mg / kg。在ICR小鼠中以20、100和180 mg / kg静脉注射SMBG后第14天评估急性毒性。死亡率,主要器官系数,血液学数据和血液生化指标表明,所有剂量的SMBG体内毒性均较低。但是,组织学检查显示高剂量时肝细胞中淋巴细胞浸润和肉芽肿形成,脾中巨核细胞增生。使用ICP-OES和TEM结果进行的硅含量分析表明,SMBGs主要分布在肝脏和脾脏的常驻巨噬细胞中,可以从体内清除超过2周。这些发现对于亚微米级颗粒的毒性评估以及用于生物医学应用的基于生物活性玻璃的药物输送系统的开发可能是重要的。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号